European Association of Dermato-Oncology 14th European School of Dermato-Oncology

Overview

The European Association of Dermato-Oncology (EADO) 14th European School of Dermato-Oncology is a comprehensive educational program that provides an up-to-date review of the fundamental principles and latest advances in the diagnosis and management of skin cancer. Designed for specialists and senior residents, the course delivers evidence-based education to strengthen clinical decision-making across the entire spectrum of dermato-oncology.

The curriculum covers all stages of skin cancer management, from early diagnosis and primary treatment to adjuvant therapy and the management of locally advanced and metastatic disease. Through expert-led educational sessions, clinical case discussions, and multidisciplinary perspectives, participants gain practical knowledge aligned with current European standards of care.

---

Course Highlights

• Comprehensive review of melanoma and non-melanoma skin cancers
• Evidence-based approaches to diagnosis, staging, and treatment
• Updates on European clinical guidelines and standards of care
• Advances in immunotherapy, targeted therapy, and multidisciplinary treatment strategies
• Practical guidance for managing treatment-related adverse events
• Emerging applications of artificial intelligence in skin cancer diagnosis
• Current approaches to adjuvant and neoadjuvant therapies
• Management of challenging and complex clinical cases

---

Learning Objectives

Upon completion of this program, participants should be able to:

• Understand the epidemiology, genetic predisposition, and molecular biology underlying the development of various skin cancers.
• Apply advanced non-invasive diagnostic techniques, including dermoscopy and reflectance confocal microscopy, to improve the diagnosis of cutaneous malignancies.
• Implement current evidence-based multidisciplinary treatment strategies for early-stage, high-risk, and metastatic skin cancers.
• Optimize the use of modern systemic therapies, including immune checkpoint inhibitors and targeted therapies, while recognizing and managing treatment-related adverse events.
• Evaluate diagnostic and therapeutic approaches for rare cutaneous malignancies, including Merkel cell carcinoma and cutaneous lymphomas.
• Integrate updated European clinical guidelines into routine skin cancer management.

---

Course Content

Foundations of Modern Skin Cancer Therapy

• Mechanisms of action of immune checkpoint inhibitors
• Principles of targeted therapies
• Integration of systemic therapies into clinical practice

Artificial Intelligence in Skin Cancer

• AI-assisted diagnostic technologies
• Current standards and emerging innovations
• Clinical applications in dermatologic oncology

Drug Innovation and Access

• Access to innovative therapies across Europe
• Regulatory and clinical considerations
• Future developments in skin cancer treatment

Adjuvant Therapy

• Current indications for adjuvant treatment
• Evidence-based treatment selection
• Improving long-term patient outcomes

Neoadjuvant Therapy

• Emerging standards of care
• Patient selection
• Clinical implementation of neoadjuvant strategies

European Clinical Guidelines

• Recent updates to European skin cancer guidelines
• Best practices for diagnosis and treatment
• Guideline-based clinical decision-making

Management of Treatment-Related Adverse Events

• Recognition of common adverse effects associated with immunotherapy, targeted therapy, hedgehog inhibitors, chemotherapy, and other systemic treatments
• Evidence-based management strategies
• Optimizing patient safety during treatment

Complex Clinical Cases

• Challenging adverse events in skin cancer therapy
• Difficult melanoma cases
• Management of keratinocyte cancers
• Multidisciplinary case discussions

Clinical Research

• Fundamentals of clinical trial design
• Conducting clinical research in dermato-oncology
• Translating research findings into clinical practice

---

Intended Audience

This educational program is intended for healthcare professionals actively involved in the diagnosis and treatment of skin cancer, including:

• Dermatologists
• Medical oncologists
• Surgical oncologists
• Radiation oncologists
• Dermatopathologists
• Specialists who have completed dermatology or oncology training
• Senior dermatology and oncology residents

The course is ideal for clinicians seeking to strengthen their expertise in evidence-based dermato-oncology, remain current with advances in skin cancer management, and improve multidisciplinary patient care across all stages of disease.